These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4959763)

  • 41. [A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. A fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria].
    Takenaka T; Tsukamura M
    Kekkaku; 1970 Mar; 45(3):93-6. PubMed ID: 4987506
    [No Abstract]   [Full Text] [Related]  

  • 42. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiological importance of resistant strains of Mycobacterium tuberculosis (experimental study)].
    Chertkova EI; Udilova NN; Chernigovskaia NN
    Probl Tuberk; 1966; 44(7):67-71. PubMed ID: 4969292
    [No Abstract]   [Full Text] [Related]  

  • 44. Vitamin B 12 synthesis by Mycobacteria. II. Isoniazid resistance & vitamin B 12 activity of Mycobacterium tuberculosis H37Rv.
    Aithal HN; Sirsi M
    Indian J Biochem; 1964 Sep; 1(3):166-7. PubMed ID: 4243420
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of the biological characteristics of strains of M. tuberculosis resistant to isoniazid and rifampin].
    Diaconescu C; Iacob L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):151-62. PubMed ID: 6093222
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experimental tuberculosis produced by phthivazid-resistant mutants of the culture H 37 Rv].
    Zemskova ZS; Sergeev VV
    Probl Tuberk; 1967; 45(9):77-82. PubMed ID: 4974608
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies of infection by drug resistant tubercle bacilli. 4. Experimental studies on infection by low-grade-resistant tubercle bacilli].
    Osato T; Kudo K; Aoki M
    Kekkaku; 1968 Dec; 43(12):503-8. PubMed ID: 4975467
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 49. Limits in tuberculosis chemotherapy as revealed by experimental study in mice.
    Kanai K; Kondo E
    Jpn J Med Sci Biol; 1971 Oct; 24(5):313-21. PubMed ID: 5003823
    [No Abstract]   [Full Text] [Related]  

  • 50. [Catalase activity of drug-resistant Mycobacterium tuberculosis strains].
    Smirnov VD
    Antibiotiki; 1971 Oct; 16(10):917-9. PubMed ID: 5003057
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 52. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 54. [Secondary resistance of tubercle bacilli to antibiotics].
    Kurdziel Z
    Przegl Lek; 1966; 22(10):645-8. PubMed ID: 4960191
    [No Abstract]   [Full Text] [Related]  

  • 55. [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis].
    De Stasio A; Puccini G
    Antibiotica; 1968 Dec; 6(4):358-62. PubMed ID: 4984521
    [No Abstract]   [Full Text] [Related]  

  • 56. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on the problems of resistance to antituberculous drugs. II--2. Clinically significant critical concentration of streptomycin, isoniazid, kanamycin and ethambutol].
    Baba H
    Kekkaku; 1994 Jun; 69(6):397-407. PubMed ID: 8041058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
    Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
    J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.